| Original language | English (US) |
|---|---|
| Pages (from-to) | 1137-1139 |
| Number of pages | 3 |
| Journal | Journal of the American Academy of Dermatology |
| Volume | 80 |
| Issue number | 4 |
| DOIs | |
| State | Published - Apr 2019 |
All Science Journal Classification (ASJC) codes
- Dermatology
Access to Document
Other files and links
Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver
}
In: Journal of the American Academy of Dermatology, Vol. 80, No. 4, 04.2019, p. 1137-1139.
Research output: Contribution to journal › Article › peer-review
TY - JOUR
T1 - The associations of depression and coping methods on health-related quality of life for those with hidradenitis suppurativa
AU - Butt, Melissa
AU - Sisic, Mia
AU - Silva, Colleen
AU - Naik, Haley B.
AU - Esmann, Solveig
AU - Jemec, Gregor
AU - Kirby, Joslyn S.
N1 - Funding Information: Dr Jemec has acted as investigator for AbbVie, Actelion, Coloplast, Janssen-Cilag, Pfizer, Pierre Fabre, Inflarx, Merck Sharp & Dome, Galderma, Leo Pharma, Novartis, Regeneron, and UCB. He has received honoraria for speaking and/or advisory boards from AbbVie, Coloplast, Pierre Fabre, Inflarx, Merck Sharp & Dome, Galderma, Leo Pharma, Novartis, and UCB, and research grants from AbbVie, Leo Pharma, and Novartis. Dr Kirby has received honoraria from AbbVie and led sponsored studies for AbbVie, Incyte, and UCB. She is also a consultant for Incyte. Dr Naik has received a research grant from AbbVie Inc. Funding Information: Dr Jemec has acted as investigator for AbbVie, Actelion, Coloplast, Janssen-Cilag, Pfizer, Pierre Fabre, Inflarx, Merck Sharp & Dome, Galderma, Leo Pharma, Novartis, Regeneron, and UCB. He has received honoraria for speaking and/or advisory boards from AbbVie, Coloplast, Pierre Fabre, Inflarx, Merck Sharp & Dome, Galderma, Leo Pharma, Novartis, and UCB, and research grants from AbbVie , Leo Pharma , and Novartis . Dr Kirby has received honoraria from AbbVie and led sponsored studies for AbbVie, Incyte, and UCB. She is also a consultant for Incyte. Dr Naik has received a research grant from AbbVie Inc .
PY - 2019/4
Y1 - 2019/4
UR - http://www.scopus.com/inward/record.url?scp=85062688780&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85062688780&partnerID=8YFLogxK
U2 - 10.1016/j.jaad.2018.09.045
DO - 10.1016/j.jaad.2018.09.045
M3 - Article
C2 - 30876533
AN - SCOPUS:85062688780
SN - 0190-9622
VL - 80
SP - 1137
EP - 1139
JO - Journal of the American Academy of Dermatology
JF - Journal of the American Academy of Dermatology
IS - 4
ER -